CN116437931A - 与严重急性呼吸综合征冠状病毒2的核衣壳蛋白特异性结合的抗体或其片段、及其用途 - Google Patents

与严重急性呼吸综合征冠状病毒2的核衣壳蛋白特异性结合的抗体或其片段、及其用途 Download PDF

Info

Publication number
CN116437931A
CN116437931A CN202180074073.3A CN202180074073A CN116437931A CN 116437931 A CN116437931 A CN 116437931A CN 202180074073 A CN202180074073 A CN 202180074073A CN 116437931 A CN116437931 A CN 116437931A
Authority
CN
China
Prior art keywords
compound
amino acid
acid sequence
antibody
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180074073.3A
Other languages
English (en)
Chinese (zh)
Inventor
川畑隆司
枡屋宇洋
柚原光佑
西村研吾
北泽宏明
黑板敏弘
矶部正治
黑泽信幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
University of Toyama NUC
Original Assignee
Toyobo Co Ltd
University of Toyama NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd, University of Toyama NUC filed Critical Toyobo Co Ltd
Publication of CN116437931A publication Critical patent/CN116437931A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/102—Coronaviridae (F)
    • C07K16/104—Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Pulmonology (AREA)
CN202180074073.3A 2020-10-30 2021-10-28 与严重急性呼吸综合征冠状病毒2的核衣壳蛋白特异性结合的抗体或其片段、及其用途 Pending CN116437931A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020183273 2020-10-30
JP2020-183273 2020-10-30
PCT/JP2021/039754 WO2022092181A1 (ja) 2020-10-30 2021-10-28 重症急性呼吸器症候群コロナウイルス２のヌクレオカプシドタンパク質に特異的に結合する抗体又はその断片、及びその用途

Publications (1)

Publication Number Publication Date
CN116437931A true CN116437931A (zh) 2023-07-14

Family

ID=81381499

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180074073.3A Pending CN116437931A (zh) 2020-10-30 2021-10-28 与严重急性呼吸综合征冠状病毒2的核衣壳蛋白特异性结合的抗体或其片段、及其用途

Country Status (5)

Country Link
US (1) US20240288427A1 (https=)
EP (1) EP4239068A4 (https=)
JP (1) JP7832430B2 (https=)
CN (1) CN116437931A (https=)
WO (1) WO2022092181A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023128698A (ja) * 2022-03-04 2023-09-14 公立大学法人横浜市立大学 変異株を含む、体液中のＳＡＲＳ－ＣｏＶ－２抗原に対する抗ＳＡＲＳ－ＣｏＶ－２抗体、該抗体を用いてＳＡＲＳ－ＣｏＶ－２を検出する方法、および該抗体を含むキット
KR20250140089A (ko) * 2023-02-08 2025-09-24 덴카 주식회사 SARS-CoV-2의 검출 방법 및 이를 위한 키트

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5779502B2 (ja) 2009-09-04 2015-09-16 国立大学法人富山大学 標的遺伝子由来配列を含む連結ｄｎａ断片の特異的作製方法
KR20130079362A (ko) 2010-03-25 2013-07-10 내셔날 유니버시티 코포레이션 유니버시티 오브 토야마 형질 세포 동정 및 단리용 형광 프로브 및 이 프로브를 이용한 형질 세포의 동정 또는 단리방법
CN111458520B (zh) * 2020-04-10 2023-09-15 中国人民解放军军事科学院军事医学研究院 新型冠状病毒AlphaLISA抗原快速检测试剂盒
CN111733141B (zh) * 2020-06-19 2022-02-18 清华大学深圳国际研究生院 一种可分泌抗新型冠状病毒n蛋白单克隆抗体的杂交瘤细胞、单克隆抗体及应用

Also Published As

Publication number Publication date
JP7832430B2 (ja) 2026-03-18
JPWO2022092181A1 (https=) 2022-05-05
EP4239068A4 (en) 2025-01-22
EP4239068A1 (en) 2023-09-06
US20240288427A1 (en) 2024-08-29
WO2022092181A1 (ja) 2022-05-05

Similar Documents

Publication Publication Date Title
CN111303279B (zh) 一种针对新型冠状病毒的单域抗体及其应用
CN102220286B (zh) 杂交瘤细胞株2c9、其产生的抗黄曲霉毒素m1单克隆抗体及其应用
CN106661110B (zh) 抗muc1抗体或其抗原结合片段及其用途
CN101993855B (zh) 杂交瘤细胞株1c11、其产生的抗黄曲霉毒素通用单克隆抗体及其应用
JP7832430B2 (ja) 重症急性呼吸器症候群コロナウイルス２のヌクレオカプシドタンパク質に特異的に結合する抗体又はその断片、及びその用途
EP3187583B1 (en) Monoclonal antibody against kir2ds1
US9453070B2 (en) Methods for detecting Th1 cells
CN105695419A (zh) 杂交瘤细胞株4C9及其产生的抗His标签蛋白单克隆抗体
CN102746403A (zh) 用于elisa检测黄曲霉毒素的标准品通用替代物、其制备方法及黄曲霉毒素elisa检测方法
EP2949675A1 (en) Humanized anti-hmgb1 antibody or antigen-binding fragment thereof
Tanaka et al. Six-transmembrane epithelial antigen of prostate4 (STEAP4) is a tumor necrosis factor alpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis
CN104181305B (zh) 抗人中性粒细胞明胶酶相关脂质运载蛋白抗体及其用途
CN120005026A (zh) 抗b7-h3单克隆抗体、杂交瘤细胞株及其应用
KR101969696B1 (ko) 메르스 코로나 바이러스 스파이크 s2 단백질에 특이적으로 결합하는 단클론 항체
KR101374758B1 (ko) 항-사이토케라틴 8/18 복합체 자가면역항체를 포함하는 암 진단 마커 및 이의 항원을 포함하는 암 진단용 조성물
JP2026071287A (ja) 重症急性呼吸器症候群コロナウイルス２のヌクレオカプシドタンパク質に特異的に結合する抗体又はその断片、及びその用途
CN102250910A (zh) 一种人可溶性b7-dc定量检测试剂盒
EP4206221A1 (en) Viral infection determination method
EP3068431A2 (en) Methods and compositions for the treatment of hcmv
CN117603348B (zh) 抗新型冠状病毒s蛋白的全人源化抗体及其应用
WO2013007667A1 (en) An antibody specifically binding to neuropilin-1
CN103555668B (zh) 杂交瘤细胞株及其产生的抗Wnt5a单克隆抗体与应用
CN110804096A (zh) Cd123单域抗体、核苷酸序列、表达载体及试剂盒
CN110655580B (zh) 一种杂交瘤细胞株及其用途
KR102007161B1 (ko) 메르스 코로나 바이러스 스파이크 s1 단백질에 특이적으로 결합하는 단클론 항체

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination